PHH Overview

Park Ha Biological Technology Co Ltd is an investment holding company primarily engaged in developing private skincare label, direct skincare products sales and franchise alliances promotions. The Company mainly operates its business through two segments. The Products Sales segment is engaged in providing skincare and cosmetic products under the brand name Park Ha as well as offering complimentary after-sales beauty services in physical stores. The Franchise Service segment is engaged in entering franchise agreements with its franchisees, pursuant to which the franchisees are granted permission to open and operate a store under the brand name Park Ha or Geni. The Company's products include Little Blue Injection Serum, Parkha Amino Acid Cleansing Foam and other products. The Company mainly conducts its business in domestic market.

Wall Street analysts forecast PHH stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for PHH is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Park Ha Biological Technology Co Ltd revenue for the last quarter amounts to 91.80 USD, increased 5.09

Park Ha Biological Technology Co Ltd. EPS for the last quarter amounts to USD, decreased

Park Ha Biological Technology Co Ltd (PHH) has 31 emplpoyees as of June 21 2026.

Today PHH has the market capitalization of 0.00 USD.